Literature DB >> 6150023

Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71.

B Nowicki, M Rhen, V Väisänen-Rhen, A Pere, T K Korhonen.   

Abstract

An immunofluorescence assay was developed to study fimbrial phase variation in a pyelonephritogenic Escherichia coli strain, KS71. By using fluorochrome-labeled antibodies specific for either P, type-1C, or type-1 fimbriae of strain KS71, it was shown that in a broth culture of strain KS71 the fimbrial types mostly occurred on different cells. Only 9% of the cells carried more than one fimbrial type. The KS71 cell population was fractionated into subpopulations expressing only one of the fimbrial types or lacking fimbriae. Immunofluorescence assay of the subpopulations revealed a rapid phase variation in fimbrial synthesis. Kinetic analyses of a nonfimbriated cell population suggested that a change from one fimbrial phase to another was not totally random.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150023      PMCID: PMC214791          DOI: 10.1128/jb.160.2.691-695.1984

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  23 in total

1.  Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors.

Authors:  I Ofek; D Mirelman; N Sharon
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

Review 2.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

3.  New Method for isolation of immunologically pure pili from Escherichia coli.

Authors:  T K Korhonen; E L Nurmiaho; H Ranta; C S Edén
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

4.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

5.  Phase variation: evolution of a controlling element.

Authors:  M Simon; J Zieg; M Silverman; G Mandel; R Doolittle
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

6.  Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli.

Authors:  G Källenius; S Svenson; R Möllby; B Cedergren; H Hultberg; J Winberg
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

7.  Attachment pili from enterotoxigenic Escherichia coli pathogenic for humans.

Authors:  C F Deneke; G M Thorne; S L Gorbach
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

8.  Bacteria-specific antibody in the urine of patients with acute pyelonephritis and cystitis.

Authors:  J J Ratner; V L Thomas; B A Sanford; M Forland
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

9.  Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae.

Authors:  I Orskov; F Orskov; A Birch-Andersen
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Hemagglutination by purified type I Escherichia coli pili.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  50 in total

1.  Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection.

Authors:  Sébastien Crépin; Sébastien Houle; Marie-Ève Charbonneau; Michaël Mourez; Josée Harel; Charles M Dozois
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli.

Authors:  B Nowicki; C Svanborg-Edén; R Hull; S Hull
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Production of cytotoxic necrotizing factor, verocytotoxin and haemolysin by pyelonephritogenic Escherichia coli.

Authors:  A Brauner; M Katouli; K Tullus; S H Jacobson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

Review 5.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

6.  Associative Nitrogen Fixation by Klebsiella spp.: Adhesion Sites and Inoculation Effects on Grass Roots.

Authors:  K Haahtela; T Laakso; T K Korhonen
Journal:  Appl Environ Microbiol       Date:  1986-11       Impact factor: 4.792

7.  In vitro adhesion of n(2)-fixing enteric bacteria to roots of grasses and cereals.

Authors:  K Haahtela; T K Korhonen
Journal:  Appl Environ Microbiol       Date:  1985-05       Impact factor: 4.792

8.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Utilization of anion-exchange chromatography and monoclonal antibodies to characterize multiple pilus types on a uropathogenic Escherichia coli O6 isolate.

Authors:  R M Gander; V L Thomas
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

10.  Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.

Authors:  Swaine L Chen; Chia S Hung; Jerome S Pinkner; Jennifer N Walker; Corinne K Cusumano; Zhaoli Li; Julie Bouckaert; Jeffrey I Gordon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.